Introduction
Chronic periodontitis is a chronic inflammatory disease that results in the destruction of the supporting connective and osseous tissues of the teeth 1) . A group of enzymes thought to be important in this degenerative process is the matrix metalloproteinase familly (MMPs) 2, 3) . Gingival fibroblasts, keratinocytes, . 1) Matrix metalloproteinases (MMPs) are a family of metal dependent proteolytic enzymes that mediate the degeneration of extracellular matrix and basement membranes 4, 5) . MMPs are composed of at least 23 related zinc or calcium dependent endopeptidases that are able to degrade extracellular matrix proteins at a pH close to neutral 6) . MMPs are secreted as inactive form (proenzyme) and are activated in the extracellular compartment or in the vicinity Two members of the MMP family, MMP-2 (72 kDa type IV collagenase, gelatinase A) and MMP-9 (92 kDa type IV collagenase, gelatinase B) especially degrade type IV collagen and are thought to specifically regulate basement membrane remodelling 8, 9) . Furthermore, they can degrade gelatin after cleavage of collagen molecules to 1/4 and 3/4 segments by interstitial collagenases ( MMP-1, MMP-13) 4, 5, 10) . And the expression levels of MMP-2 and MMP-9 can be considered as a good indicator for diagnosis of periodontal disease.
The actions of collagenolytic enzymes are controlled at least at three distinct levels involving production, activation and inhibition 11) . First, the enzymes are synthesized and secreted in an inactive proform. Second, the enzymes are activated by autoactivation, by stromelysin, or plasmin. Third, once activated, the enzymes perform their catalytic activities and are subsequently inhibited by specific tissue inhibitors of metalloproteinases (TIMPs). MMP-2 and MMP-9 known as gelatinase A and B, respectively, are active in the degradation of denatured fibrillar collagens, elastin and several other components of the extracellular matrix5, [12] [13] [14] . There are several evidences indicating that MMP-2 and MMP-9 play an important role in tissue destruction during periodontal disease 4, 12, 15) . Patients with chronic periodontitis have significantly higher levels of MMP-2 and MMP-9 than healthy subjects, and the amount of them decreases after periodontal . Based on theses facts it can be assumed that MMP-2 and MMP-9 contribute to chronic periodontitis with diabetes mellitus differently. But whether and to what degree diabetes affects the expression and activity of the MMP induction / activation system in patients with diabetes remains unknown.
Diabetes mellitus is one of the main contributing factor for periodontal disease and limiting factor for periodontal treatment including implant therapy. Although diabetes itself does not cause periodontitis, periodontal disease progresses more rapidly and leads to more tooth losses in patients with poorly controlled blood gluose [18] [19] [20] . Severe periodontitis has been associated with an increased risk of poor glycemic control and, in turn untreated advanced periodontal disease can deteriorate the metabolic control of diabetes [21] [22] [23] . Various pathogenetic factors have been suggested to explain the increased prevalence and severity of periodontitis in diabetes 22, 23) . Numerous studies of PMNLs function in patient with diabetes have shown impaired chemotaxis, adherence, phagocytosis, and suggest these defects could lead to impaired host resistance to infection.
The severity of periodontitis has been correlated with defective chemotaxis, which may be linked to extensive periodontal tissue destruction; diabetic patients with severe periodontitis had depressed PMN chemotaxis compared to those with mild periodontitis or non-diabetic subjects with severe or mild periodontitis 24, 25) 
Ststistical Analysis of the Western blot results
All data were presented as means ± standard deviation and results were statistically analyzed. The MMP-2, MMP-9 and TNF-α levels among each 3 groups were compared using one way ANOVA followed by Scheffe test. P value <0.05 was considered to statistically significant.
Results
To compare MMP-2 protein levels in human gingiva with chronic periodontitis with or without associated to Type 2 diabetes mellitus under these conditions, antibodies to MMP-2 cross-reacted with about 72 KDa molecular weight of MMP-2 in all three groups (Figure 1 ). In order to quantify the level of MMP-2 in the groups, the levels of β-actin were also meas- Table 1 . MMP-2 intensity was normalized by β-actin intensity to quantify the expression levels of MMP-2 protein and the value were presented as a ratio of MMP-2/β-actin. MMP-2 corresponding to molecular weight 72 kDa was shown to be expressed in all samples including healthy gingiva, and the expression levels of MMP-2 were increased in patients with type 2 diabetes mellitus than in control healthy subjects. In order to quantify the MMP-2 levels, β-actin levels were also performed. Group 1：healthy gingiva from systemically healthy person Group 2：inflammed gingiva from patient with chronic periodontitis Group 3：inflammed gingiva from patient with chronic periodontitis and type 2 DM ured by anti-β-actin specific western blot analysis. Then MMP-2 levels were normalized by β-actin (ratio of MMP-2/β-actin). The expression levels of MMP-2 in each sample
were measured by densitometer. The levels of gingival MMP-2 protein are given in Table 1 .
The mean amount of MMP-2 (ratio of MMP-2/β-actin) were 3.249 in group 1, 3.760 in group 2, 3.876 in group 3. The amount of MMP-2 was higher in group 3 than in group 1.
Also higher amount of MMP-2 was seen in group 3 compared to group 2. But, the differences among three groups were not statistically significant (P>0.05). MMP-9 corresponding to molecular weight 92 kDa was shown to be expressed in all samples including healthy gingiva and the expression levels of MMP-9 were increased in patients with type 2 diabetes mellitus than in control healthy subjects. In order to quantify detected MMP-9, β-actin levels were also measured. Group 1：healthy gingiva from systemically healthy person Group 2：inflammed gingiva from patient with chronic periodontitis Group 3：inflammed gingiva from patient with chronic periodontitis and type 2 DM
The comparison of MMP-9 protein level western blot analysis using the antibodies against MMP-9 detected about 92 kDa molecular weight of MMP-9 in all three groups ( Figure 3) .
Generally, the bands seemed to be thicker in Figure 4 . Graphics showing the average amounts (Ratio of MMP-9/β-actin) and standard deviation of gelatinase MMP-9 in group 1, 2 and 3. In the inflamed gingiva (with or without diabetes, group 2 & 3), the levels of MMP-9 was higher compared to healthy gingiva. The difference between group 3 and group 1 was statistically significant (P<0.05). * significant difference between group 1 and group 3 (P<0.05) Group 1：healthy gingiva from systemically healthy person Group 2：inflammed gingiva from patient with chronic periodontitis Group 3：inflammed gingiva from patient with chronic periodontitis and type 2 DM Table 2 . MMP-9 intensity was normalized by β-actin intensity to quantify the expression levels of MMP-9 protein and the value were presented as a ratio of MMP-9/β-actin. * group 3 compared to group 1 and 2. The levels of MMP-9 proteins were also quantified ( Figure   3 ). The levels of individual gingival MMP-9 are given in Table 2 . MMP-9 in each sample and mean amounts of MMP-9 in three different groups were compared (Table 2 ) and (Figure 4 ).
The mean amounts of MMP-9 (ratio of MMP-9/ β-actin) were 1.011 in group 1, 1.449 in group 2 and 1.897 in group 3. The MMP-9 levels in group 3 were thicker than in group 1 (P<0.05).
In the comparison of TNF-α protein levels using Western blot analysis, TNF-α of about 17 kDa molecular weight was identified and quantified (Table 3) Table 3 . TNF-α intensity was normalized by β-actin intensity to quantify the expression levels of TNF-α protein and the value were presented as a ratio of TNF-α/β-actin. Figure 5 . TNF-α Western analysis showing 4 representative samples in each group. TNF-α corresponding to molecular weight 17 kDa was expressed in all samples including healthy gingiva and the expression levels of TNF-α were not increased significantly in patients with type 2 diabetes mellitus than in control subjects. In order to quantify the TNF-α levels, β-actin levels were also measured. .
MMP-2 and MMP-9 is thought to play an . These differences in cell lines could influence on inflammation resulting in higher expression level of MMP-9.
In the case of MMP-9 the expression of activity showed elicit increasing tendency in 2. As MMP-2 levls were increasing, MMP-9 levels also were increased comparing to MMP-2 levels between group 2 and group 3. But there were no statistically significant difference between MMP-2 and MMP-9.
3. As expression of TNF-α were increased, MMP-2 and MMP-9 expressions showed increasing tendency in Group 3 than Group 1 and Group 2, although there were no proportional relationship.
In conclusion, this study demonstrated that although there were no proportional relationship between the interrelationship of MMP-2, MMP-9 and TNF-α,. as expression of TNF-α were increased, MMP-2, MMP-9 expressions showed increasing tendency in chronic periodontitis associated to type 2 DM.
It can be assumed that TNF-α in part affect to expression of MMP-2 and MMP-9 in progression of periodontal inflammation associated to type 2 DM
